Update on quinolone-containing rescue therapies for <i>Helicobacter pylori</i> infection
この論文をさがす
説明
Third generation of quinolones, such as levofloxacin and moxifloxacin, -containing regimens are often used in second-line or rescue treatment of Helicobacter pylori infection. However, the increasing antibiotic resistance to quinolones affects the efficacies of quinolones-containing therapies in recent years. Therefore, there is a need to enhance the effectiveness of quinolones-containing therapies. Sitafloxacin, a fourth-generation quinolone, and vonoprazan, a novel potassium-competitive acid blocker, are now available as more effective treatment options. The aim of this paper is to summarize the current evidence of quinolone-containing therapies in rescue treatments, and to discuss the importance of drug sensitivity tests or analysis of gyrA mutation before treatments.
収録刊行物
-
- World Journal of Gastroenterology
-
World Journal of Gastroenterology 26 (15), 1733-1744, 2020-04-21
Baishideng Publishing Group Inc.
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1360853567372275968
-
- ISSN
- 10079327
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE
